A special protein can play a key role in the fight against certain types of prostate cancer. This is shown in a study by an international research group led from , Sweden.
Availability of numerous biosimilars has rendered low-cost options for patients, therefore, increased adoption rates for EPO drugs particularly in developing regions, which boosts the market growth.
A special protein can play a key role in the fight against certain types of prostate cancer. Until now, treatments have involved blocking the protein in question that builds a so-called signalling ...
It’s that time of year when our skin and lips get dry, cracked, uncomfortable and even painful at times. A Maine-based company that uses a lobster byproduct for its lotions and treatment has a ...
Senior Department of Ophthalmology, the Third Medical Center of Chinese People’s Liberation Army (PLA) General Hospital & Chinese PLA Medical School, Beijing, China Background: Bilateral optic ...
To enable a new generation of anti-viral vaccines, we designed self-assembling protein nanoparticles with geometries tailored to present the ectodomains of influenza, HIV, and RSV viral glycoprotein ...